October 22, 2019 | BY Deborah Dormady LethamIn identifying human and animal cell lines, it’s all about the traceability.
October 21, 2019 | BY Regina Keldern the wake of amyloid beta, companies eye tau and neuroinflammation as Alzheimer’s drug targets. Live from Neuroscience 2019,
October 21, 2019 | BY Regina KelderHow antisense oligonucleotides are moving from obscurity to a viable drug strategy. Our live coverage of Neuroscience 2019 continues.
October 20, 2019 | BY Regina KelderHuman-derived models are an exciting alternative, but rodents are still relevant. Our coverage of Neuroscience 2019 continues
October 20, 2019 | BY Regina KelderResearch is growing in the links between neuroinflammation and a number of stubborn CNS diseases. Day one of our live Neuroscience 2019
October 17, 2019 | BY Mary ParkerThe Society for Neuroscience meeting is getting underway this weekend. Charles River scientists discuss how automation is speeding up ion channel research
October 16, 2019 | BY Eureka StaffHow artificial intelligence is making waves in drug discovery; tips and trends in outsourcing drug development to CROs
October 11, 2019 | BY Mary ParkerAlso: STDs rise in the US for the five year in a row, and hope for schizophrenia patients
October 10, 2019 | BY Regina KelderHow physicians and scientists teamed up for one little girl born with a deadly form of Batten disease
October 9, 2019 | BY Regina KelderA Charles River-led study describes the tide of regulatory creep emerging in how we measure CNS toxicity
